What is CaNCURE?

CaNCURE was created in 2015 to provide Northeastern University undergrads with experiential training in cancer nanomedicine.  Sixty-six trainees have already completed the program so far, and we expect to train another eighty-nine students in the next 5 years.
Our co-op students spend 6-months performing hands-on research in a NCI-funded research laboratory.   This research experience is supplemented with research and bio/nano innovation seminars, professional development activities, and opportunities to present research.
Our alumni have successfully found new co-op and jobs in cancer research, scholarships to medical school, and scholarships to graduate school.  58% of alumni are currently performing cancer research.

75

Trainees

29

Mentors

31

Publications

118

Presentations


Hear from our Alumni:

“Seeing my grandmother battle a multitude of cancers (and be alive and well today!) has inspired me.  Through CaNCURE, I get to work in the clinical radiology department at Dana-Farber Cancer Institute to analyze clinical trial data from patients with glioblastoma multiforme (an aggressive brain cancer). My future goals include medical school, where I would like to continue my research and clinical involvement with the brain.”

Amanda Stroiney, Behavioral Neuroscience, ’16


Trainee Spotlight


Courtney Fraser

Health Science, '21

The Development and Characterization of Monoclonal Antibodies for Integrins and TGF-b

Marina Yamada

Health Science, '21

Triple-targeted Photonanomedicine: A Strategy to Treat Heterogeneous Tumors

Mia Wallach

Business (w Concentration in Healthcare Management and Consulting), '23

Nano-Talazoparib and Nano-Dinaciclib Combination Therapy for Lung Cancer Cells

Featured Trainee Publication


Upcoming Events

Check back soon for new events


Mentor Spotlight


Tayyaba Hasan, Ph.D.

Professor of Dermatology, HMS

Our group has extensive expertise in the photodynamic therapy of cancer, infections, and infectious disease, as well as targeted drug delivery using site-directed photochemistry. Students will participate in the design and testing of photoactivatable nanoparticles for the treatment of ovarian, prostate, pancreatic, or head and neck cancer.


Anne Klibanski, M.D.

Physician in Medicine,,

Studies the pathogenesis and hormone regulation of pituitary tumors, with the goal of identifying more effective therapies for endocrine tumor treatment. Students will have the opportunity to test and validate new therapeutic strategies in vitro, as well as analyze clinical trial data.


Trainee Spotlight


Rodrigo Blanco Bravo

Bioengineering, '22

Multiplexed cellular fluorescent imaging in head and neck squamous cell carcinomas (HNSCC) for different markers to predict patient specific response rates to immunotherapy and for mapping of the tumor microenvironment (TME).

Mia Wallach

Business (w Concentration in Healthcare Management and Consulting), '23

Nano-Talazoparib and Nano-Dinaciclib Combination Therapy for Lung Cancer Cells

Claire Buxton

Molecular Biology, '21

Role of ESRP1/ESRP2 splicing regulators in the development of Triple-Negative Breast Cancer


 Get Involved

Interested in learning how nanomedicine is used to detect and treat cancer? Want to get involved in developing new nanotechnologies for the clinic? We are looking to match undergrads at Northeastern University with leading Boston researchers and clinicians for a six-month, hands-on research experience.  If you are thinking about a career in cancer science, engineering, or medicine, come get involved in the world’s first undergraduate program in cancer nanomedicine!  We have 9 upcoming openings for the January – June 2019 co-op period.  We will be accepting applications starting in September 2018 via NUcareers.

Going on in the lab right now...